ELTX compared with ALDX: revenue, margins and what each company keeps, and the suppliers and customers both name

ELTXElicio Therapeutics, Inc.

Mkt capRevenueRevenue

ALDXAldeyra Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ELTXElicio Therapeutics, Inc.

ALDXAldeyra Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ELTX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.7%▼−1.90%×0.10

ALDX

0 of 3at or beyond implied

Reportimpliedrealized× implied

May 4 '23±13.6%▲+2.06%×0.15

Mar 9 '23±7.5%▲+7.19%×0.96

= impliedELTX realized, solidALDX realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

Nov 10 '22

—

▲+6.18%

—

Aug 5 '22±19.4%▲+10.90%×0.56

ELTXElicio Therapeutics, Inc.

1.69▼−3.18%· post 1.69

Mkt cap$44.2M

ALDXAldeyra Therapeutics, Inc.

0.66▲+0.73%· post 0.57

ClosedOct 30 '26

Mkt cap$33.8M

Compare

ClosedOct 30 '26

ELTXElicio Therapeutics, Inc.

ALDXAldeyra Therapeutics, Inc.

1.69▼−3.18%post 1.69

Price

0.66▲+0.73%post 0.57

$44.2M

Mkt cap

$33.8M

ELTX1.69▼−3.18%vsALDX0.66▲+0.73%ClosedOct 30 '26